Razvi Salman S, Wild Helen, Ingoe Lorna, Vernazza Jonathan, Vanderpump Mark, Pearce Simon H S, Ludgate Marian
Translational and Clinical Research Institute, Newcastle University Centre for Life, Central Parkway, Newcastle upon Tyne NE1 3BZ, UK.
Department of Endocrinology, Gateshead Health NHS Foundation Trust, Gateshead NE9 6SX, UK.
J Clin Endocrinol Metab. 2025 Aug 7;110(9):e3078-e3084. doi: 10.1210/clinem/dgae875.
Longitudinal studies of thyroid function have demonstrated differing results. It remains unclear whether changes in thyroid function affect the diagnosis of subclinical thyroid dysfunction with aging.
Survivors of the Whickham cohort study were evaluated on 2 occasions between the years 2008 and 2012 and 2016 and 2019. Serum TSH, free T4 (FT4), free T3 (FT3), and thyroid peroxidase antibody (TPOAb) were measured on both occasions using the same assay under similar conditions. Individuals with known thyroid disease or on medications affecting thyroid function were excluded. Comorbidities were noted, functional mobility was assessed by the timed up-and-go test, and muscle function was evaluated by the hand grip strength test.
In 204 individuals (mean age 77.0 [±6.6] years, 114 [56%] female), followed over a median (interquartile range) of 7.8 (7.3-8.2) years, serum TSH increased by 0.29 mU/L (12.4%), FT3 and TPOAb reduced by 0.1 pmol/L (-2.1%) and 0.6 U/L (-11.2%), and there were no significant changes in FT4 levels. The calculated upper limit of serum TSH increased over the follow-up period from 4.74 mU/L to 6.28 mU/L. The relationship between serum TSH and FT4 at both time points was not significantly different. Utilizing standard laboratory reference ranges, the prevalence of subclinical hypothyroidism increased from 3.5% at baseline to 9.0% at follow-up. However, adopting a visit-specific TSH reference range reduced the prevalence of subclinical hypothyroidism at both time points to 2.0%.
Thyroid function demonstrates subtle but significant changes with age. Utilizing standard reference ranges tends to increase the diagnosis of subclinical hypothyroidism in older euthyroid individuals. Our data suggest that adopting age-appropriate TSH reference ranges may reduce the risk of diagnosing and (potentially unnecessarily) treating subclinical hypothyroidism.
甲状腺功能的纵向研究结果各异。甲状腺功能变化是否会影响亚临床甲状腺功能减退症随年龄增长的诊断仍不明确。
对威克姆队列研究的幸存者在2008年至2012年以及2016年至2019年期间进行了两次评估。在相似条件下使用相同检测方法在两个时间点测量血清促甲状腺激素(TSH)、游离甲状腺素(FT4)、游离三碘甲状腺原氨酸(FT3)和甲状腺过氧化物酶抗体(TPOAb)。排除已知患有甲状腺疾病或正在服用影响甲状腺功能药物的个体。记录合并症,通过计时起立行走测试评估功能活动能力,并通过握力测试评估肌肉功能。
在204名个体(平均年龄77.0 [±6.6]岁,114名[56%]为女性)中,随访中位时间(四分位间距)为7.8(7.3 - 8.2)年,血清TSH升高0.29 mU/L(12.4%),FT3和TPOAb分别降低0.1 pmol/L(-2.1%)和0.6 U/L(-11.2%),FT4水平无显著变化。随访期间计算出的血清TSH上限从4.74 mU/L增加到6.28 mU/L。两个时间点血清TSH与FT4之间的关系无显著差异。利用标准实验室参考范围,亚临床甲状腺功能减退症的患病率从基线时的3.5%增加到随访时的9.0%。然而,采用特定访视的TSH参考范围可将两个时间点亚临床甲状腺功能减退症的患病率降至2.0%。
甲状腺功能随年龄增长呈现细微但显著的变化。使用标准参考范围往往会增加老年甲状腺功能正常个体中亚临床甲状腺功能减退症的诊断。我们的数据表明,采用适合年龄的TSH参考范围可能会降低诊断和(可能不必要地)治疗亚临床甲状腺功能减退症的风险。